News

Find News

Filter articles

Showing 2831 to 2840 of 2887 results

Teva and Sun stung by $2 billion settlement

US14-06-2013

Generic drug-makers Teva Pharmaceutical and Sun Pharmaceutical have agreed to pay a combined $2.15 billion to settle a patent infringement case over Pfizer’s heartburn drug Protonix.

US Supreme Court strikes Myriad blow

US13-06-2013

The US Supreme Court has ruled that isolated human DNA is not patent eligible and has struck down patents owned by biotech company Myriad, ending a long-running and controversial case.

IPAB sets aside Sutent patent rejection

India07-06-2013

India’s Intellectual Property Appellate Board has set aside a decision revoking a Pfizer-licensed patent directed to cancer drug Sutent.

Shire settles with Teva over ADHD drug

US04-06-2013

Drug-maker Teva must wait until 2015 before selling generic versions of Shire’s Intuniv product, according to a patent settlement between the companies.

Takeda sues generics over heartburn drug

US31-05-2013

Japanese pharma company Takeda has sued generic drug-makers Impax and Sandoz for allegedly infringing a patent directed to its anti-heartburn drug Dexilant.

Amgen and Astellas join forces in Japan

Japan, US30-05-2013

California-based biotechnology company Amgen has entered into a long-term partnership with Japanese pharmaceutical company Astellas Pharmas Inc to provide new medicines in Japan.

Patents covering IVF test spark row

US29-05-2013

Members of the scientific community have blasted Stanford University and US biotechnology company Auxogyn for their involvement in patenting a test designed to increase the success of in vitro fertilisation (IVF).

Hi-tech and life sciences dominate at EPO awards

EU29-05-2013

The inventor of the world’s first flat-panel liquid crystal display, Martin Schadt, was among a number of winners at the European Patent Office European Inventor Award 2013.

WHO issues IP warning over MERS virus

28-05-2013

The World Health Organization has warned that “no IP will stand in the way of public health actions” amid the spreading of a deadly global virus.

Actavis to buy Warner Chilcott

Ireland, US22-05-2013

Actavis announced on May 20 it will acquire specialty pharmaceutical company Warner Chilcott plc in a deal worth an estimated $5 billion.

Showing 2831 to 2840 of 2887 results

LSIPR